DongKook Pharmaceutical Revenue

DongKook Pharmaceutical had revenue of 226.81B KRW in the quarter ending September 30, 2025, with 12.91% growth. This brings the company's revenue in the last twelve months to 894.93B, up 13.41% year-over-year. In the year 2024, DongKook Pharmaceutical had annual revenue of 812.17B with 11.10% growth.

Revenue (ttm)

894.93B

Revenue Growth

+13.41%

P/S Ratio

0.94

Revenue / Employee

725.82M

Employees

1,211

Market Cap

838.85B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	812.17B	81.17B	11.10%
Dec 31, 2023	730.99B	69.35B	10.48%
Dec 31, 2022	661.65B	67.45B	11.35%
Dec 31, 2021	594.19B	35.09B	6.28%
Dec 31, 2020	559.10B	76.82B	15.93%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	5,504.84B
Celltrion	3,895.99B
ALTEOGEN	202.18B
ABL Bio	88.44B
SK Biopharmaceuticals	675.41B
Yuhan	2,136.67B
LigaChem Biosciences	159.27B
Peptron	6.19B

Revenue Rankings